Information Provided By:
Fly News Breaks for August 2, 2018
MOH
Aug 2, 2018 | 08:26 EDT
SunTrust analyst David MacDonald raised his price target on Molina Healthcare to $140 and kept his Buy rating after its "blowout" Q2 results driven by "stronger premium revenue, sequential MCR improvement, solid G&A expense control, and marketplace outperformance." The analyst also cites the company's improving capital structure and "meaningful" margin expansion, raising his FY18 EPS view to $7.52 from $4.58.